Sign in
Stories
Diabetic Retinology Market Set to Reach USD 13.23 Billion by 2031
Share
Advancements and Challenges in Ophthalmo...
Advancements in Cancer Treatment and Mar...
Avenova-branded Products in EU Market
4D Molecular Therapeutics Raises $300 Mi...
4DMT Presents Positive Interim Data
ANJESO Drug Insight and Market Forecast
Overview
API
The global diabetic retinology market is projected to reach USD 13.23 billion by 2031, driven by factors such as the increasing prevalence of diabetes and advancements in diagnostic technologies. Major vendors include Bayer, Abbvie, Novartis, EYESONIC, and more. The North American market is expected to dominate, with Diabetic Macular Edema (DME) holding the largest market share.
Ask a question
How can the rising prevalence of diabetes be managed effectively?
What are some advancements in diagnostic technologies for diabetic retinology?
What other regions are expected to contribute significantly to the diabetic retinology market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage